Pharma
1 min read

WHO chief scientist disappointed by CureVac trial

German biotech firm CureVac' vaccine proved only 47% effective in an initial trial read-out.

Reuters

Updated On Jun 19, 2021 at 06:31 PM IST

Geneva- The World Health Organization's chief scientist said on Friday that results from the CureVac COVID-19 vaccine's initial trial were disappointing.

German biotech firm CureVac' vaccine proved only 47% effective in an initial trial read-out.

"It was disappointing to see the results from CureVac," the WHO's Soumya Swaminathan told a news conference.

(Reporting by Mike Shields and John Miller; Writing by Giles Elgood; Editing by Alison Williams)